Related references
Note: Only part of the references are listed.Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells
Somayeh Vandghanooni et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
A highly sensitive colorimetric aptasensor for the detection of the vascular endothelial growth factor in human serum
Jiajia Dong et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)
In Vitro Selection of New DNA Aptamers for Human Vascular Endothelial Growth Factor 165
Sepehr Manochehry et al.
CHEMBIOCHEM (2020)
Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs
Claudia Riccardi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
An aptamer-based four-color fluorometic method for simultaneous determination and imaging of alpha-fetoprotein, vascular endothelial growth factor-165, carcinoembryonic antigen and human epidermal growth factor receptor 2 in living cells
Jiayao Xu et al.
MICROCHIMICA ACTA (2019)
The Growing Development of DNA Nanostructures for Potential Healthcare-Related Applications
Divita Mathur et al.
ADVANCED HEALTHCARE MATERIALS (2019)
A signal-on nanobiosensor for VEGF165 detection based on supraparticle copper nanoclusters formed on bivalent aptamer
Fatemeh Mortazavi Moghadam et al.
BIOSENSORS & BIOELECTRONICS (2019)
Photoelectrochemical aptamer-based sensing of the vascular endothelial growth factor by adjusting the light harvesting efficiency of g-C3N4 via porous carbon spheres
Ya-Ling Liu et al.
MICROCHIMICA ACTA (2019)
Design and optimisation of Photochrome Aptamer Switch Assay (PHASA)
Yubin Zhou et al.
ANALYTICA CHIMICA ACTA (2019)
Potent anti-angiogenesis and anti-tumour activity of pegaptanib-loaded tetrahedral DNA nanostructure
Xueping Xie et al.
CELL PROLIFERATION (2019)
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one!
Federica Moccia et al.
NUCLEIC ACIDS RESEARCH (2019)
Investigating the properties of TBA variants with twin thrombin binding domains
Teresa Amato et al.
SCIENTIFIC REPORTS (2019)
Molecular affinity rulers: systematic evaluation of DNA aptamers for their applicabilities in ELISA
Michiko Kimoto et al.
NUCLEIC ACIDS RESEARCH (2019)
G-Quadruplex-Forming Aptamers-Characteristics, Applications, and Perspectives
Carolina Roxo et al.
MOLECULES (2019)
Bimodular Antiparallel G-Quadruplex Nanoconstruct with Antiproliferative Activity
Olga Antipova et al.
MOLECULES (2019)
Unraveling Determinants of Affinity Enhancement in Dimeric Aptamers for a Dimeric Protein
Sepehr Manochehry et al.
SCIENTIFIC REPORTS (2019)
A chemiluminescent dual-aptasensor capable of simultaneously quantifying prostate specific antigen and vascular endothelial growth factor
Junhyun Chong et al.
ANALYTICAL BIOCHEMISTRY (2019)
Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells
Sana Batool et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
Development of Aptamer-Based TID Assays Using Thermophoresis and Microarrays
Tracy Kurth et al.
BIOSENSORS-BASEL (2019)
Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion
Shudi Yang et al.
MOLECULAR PHARMACEUTICS (2018)
Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): A review
Sadegh Dehghani et al.
BIOSENSORS & BIOELECTRONICS (2018)
A highly sensitive VEGF(165) photoelectrochemical biosensor fabricated by assembly of aptamer bridged DNA networks
Huimei Da et al.
BIOSENSORS & BIOELECTRONICS (2018)
Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer
Somayeh Vandghanooni et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers
Claudia Riccardi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Chloe J. Peach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Aptamer adaptive binding assessed by stilbene photoisomerization towards regenerating aptasensors
Yubin Zhou et al.
SENSORS AND ACTUATORS B-CHEMICAL (2018)
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
Megan Stevens et al.
GENES (2018)
Current Advances in Aptamers for Cancer Diagnosis and Therapy
Shin-ichiro Hori et al.
CANCERS (2018)
Recent developments in cell-SELEX technology for aptamer selection
Harleen Kaur
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
SELEX methods on the road to protein targeting with nucleic acid aptamers
Payam Bayat et al.
BIOCHIMIE (2018)
Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective
Somayeh Vandghanooni et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Targeted VEGF-triggered release of an anti-cancer drug from aptamer-functionalized metal-organic framework nanoparticles
Wei-Hai Chen et al.
NANOSCALE (2018)
Electrochemical Biosensors - Sensor Principles and Architectures
Dorothee Grieshaber et al.
SENSORS (2018)
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies
Claudia Riccardi et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells
Somayeh Vandghanooni et al.
NANOMEDICINE (2018)
Electrochemical Detection of VEGF165 Lung Cancer Marker Based on Au-Pd Alloy Assisted Aptasenor
Huinan Ye et al.
INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE (2017)
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
Deok-Hoon Kong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer
Pengchao Sun et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Circular Bivalent Aptamers Enable in Vivo Stability and Recognition
Hailan Kuai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics
Domenica Musumeci et al.
CANCERS (2017)
Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges
Kodappully Sivaraman Siveen et al.
CURRENT VASCULAR PHARMACOLOGY (2017)
G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms
Paula J. Bates et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
G-quadruplex-based aptamers against protein targets in therapy and diagnostics
Chiara Platella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers
Nonkululeko N. Mthembu et al.
HIV AIDS-RESEARCH AND PALLIATIVE CARE (2017)
Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy
Dan Chen et al.
BIOMATERIALS (2016)
Structural regulation by a G-quadruplex ligand increases binding abilities of G-quadruplex-forming aptamers
Kaori Tsukakoshi et al.
CHEMICAL COMMUNICATIONS (2016)
Electrochemical aptasensor for the detection of vascular endothelial growth factor (VEGF) based on DNA-templated Ag/Pt bimetallic nanoclusters
Xian-Ming Fu et al.
CHINESE CHEMICAL LETTERS (2016)
A label-free fluorescent aptasensor for selective and sensitive detection of streptomycin in milk and blood serum
Seyed Mohammad Taghdisi et al.
FOOD CHEMISTRY (2016)
Aptamers: The evolution of SELEX
Yi Xi Wu et al.
METHODS (2016)
Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications
Mariya Vorobyeva et al.
MOLECULES (2016)
Methods for Improving Aptamer Binding Affinity
Hijiri Hasegawa et al.
MOLECULES (2016)
Ten years of anti-vascular endothelial growth factor therapy
Napoleone Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Fit for the Eye: Aptamers in Ocular Disorders
Daniel W. Drolet et al.
NUCLEIC ACID THERAPEUTICS (2016)
Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects
Wei Tao et al.
THERANOSTICS (2016)
Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing
Christopher H. Stuart et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and-2, in a Mouse Model of Hepatocellular Carcinoma
Takuji Torimura et al.
NEOPLASIA (2016)
Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers
Yuanyuan Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Current approaches in SELEX: An update to aptamer selection technology
Mariia Darmostuk et al.
BIOTECHNOLOGY ADVANCES (2015)
Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition
Stacey L. Edwards et al.
CHEMICAL COMMUNICATIONS (2015)
Nucleic acid aptamers in cancer research, diagnosis and therapy
Haitao Ma et al.
CHEMICAL SOCIETY REVIEWS (2015)
Improvement of the VEGF binding ability of DNA aptamers through in silico maturation and multimerization strategy
Takahiro Fukaya et al.
JOURNAL OF BIOTECHNOLOGY (2015)
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents
Domenica Musumeci et al.
MOLECULES (2015)
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
T. Dragovich et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
One-pot synthesized DNA-templated Ag/Pt bimetallic nanoclusters as peroxidase mimics for colorimetric detection of thrombin
Cheng Zheng et al.
CHEMICAL COMMUNICATIONS (2014)
Roles of VEGF-A signalling in development, regeneration, and tumours
Ken Matsumoto et al.
JOURNAL OF BIOCHEMISTRY (2014)
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas
Jeffrey J. Raizer et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Redox-active gold nanoclusters immobilized ZnO nanorod electrodes for electrochemical sensing applications
Green Baek et al.
RSC ADVANCES (2014)
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
Baby Santosh et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Jiehua Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Affinity Improvement of a VEGF Aptamer by in Silico Maturation for a Sensitive VEGF-Detection System
Yoshihiko Nonaka et al.
ANALYTICAL CHEMISTRY (2013)
Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance
Alexander Levitzki
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Jaafar Bennouna et al.
LANCET ONCOLOGY (2013)
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Michiko Kimoto et al.
NATURE BIOTECHNOLOGY (2013)
G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold
Maja Marusic et al.
NUCLEIC ACIDS RESEARCH (2013)
Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer Cells
Harleen Kaur et al.
PLOS ONE (2013)
Development of a Multiplex Sandwich Aptamer Microarray for the Detection of VEGF165 and Thrombin
Alice Sosic et al.
SENSORS (2013)
Aflibercept in wet AMD: specific role and optimal use
F. Semeraro et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
A Systematic Study of the Features Critical for Designing a High Avidity Multivalent Aptamer
Xiaoching Zhao et al.
NUCLEIC ACID THERAPEUTICS (2013)
CD28 Aptamers as Powerful Immune Response Modulators
Fernando Pastor et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)
T. C. Gauler et al.
ANNALS OF ONCOLOGY (2012)
Nucleic acid aptamers: an emerging frontier in cancer therapy
Guizhi Zhu et al.
CHEMICAL COMMUNICATIONS (2012)
Aptamers as Remarkable Diagnostic and Therapeutic Agents in Cancer Treatment
Henri-Pierre Lassalle et al.
CURRENT DRUG METABOLISM (2012)
Electrochemical Detection of Vascular Endothelial Growth Factor with Aptamer Sandwich
Yoshihiko Nonaka et al.
ELECTROCHEMISTRY (2012)
Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial
Rodryg Ramlau et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Selection is more intelligent than design: improving the affinity of a bivalent ligand through directed evolution
Kareem M. Ahmad et al.
NUCLEIC ACIDS RESEARCH (2012)
Probing High Affinity Sequences of DNA Aptamer against VEGF165
Harleen Kaur et al.
PLOS ONE (2012)
Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Anti-VEGF Therapies in the Clinic
Kellen L. Meadows et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
PHASE 2 RANDOMIZED, NONCOMPARATIVE, OPEN-LABEL STUDY OF AFLIBERCEPT AND MODIFIED FOLFOX6 IN THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (AFFIRM)
Carles Pericay et al.
ANNALS OF ONCOLOGY (2012)
A folding-based electrochemical aptasensor for detection of vascular endothelial growth factor in human whole blood
Shuang Zhao et al.
BIOSENSORS & BIOELECTRONICS (2011)
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia
Prabodhika R. Mallikaratchy et al.
NUCLEIC ACIDS RESEARCH (2011)
Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
Thomas Schmidt et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Target-Responsive Structural Switching for Nucleic Acid-Based Sensors
Di Li et al.
ACCOUNTS OF CHEMICAL RESEARCH (2010)
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
Sven Mahner et al.
BMC CANCER (2010)
A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activity
Jung-Wook Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action
Napoleone Ferrara
MOLECULAR BIOLOGY OF THE CELL (2010)
Screening and Improvement of an Anti-VEGF DNA Aptamer
Yoshihiko Nonaka et al.
MOLECULES (2010)
Biophysical Characterization of DNA Aptamer Interactions with Vascular Endothelial Growth Factor
Ajish S. R. Potty et al.
BIOPOLYMERS (2009)
Why are tumour blood vessels abnormal and why is it important to know?
J. A. Nagy et al.
BRITISH JOURNAL OF CANCER (2009)
Nucleic Acid Aptamers Based on the G-Quadruplex Structure: Therapeutic and Diagnostic Potential
B. Gatto et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia
Nuria Barbarroja et al.
EXPERIMENTAL HEMATOLOGY (2009)
Role and Therapeutic Potential of VEGF in the Nervous System
Carmen Ruiz De Almodovar et al.
PHYSIOLOGICAL REVIEWS (2009)
1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor
Wayne J. Fairbrother et al.
PROTEIN SCIENCE (2009)
Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method
Hijiri Hasegawa et al.
BIOTECHNOLOGY LETTERS (2008)
Quantitative Analysis of Vascular Endothelial Growth Factor in Liver Metastases from Pancreatic Carcinoma as a Predictor of Chemotherapeutic Effect and Prognosis
Katsunobu Tawada et al.
CLINICAL CANCER RESEARCH (2008)
SELEX with modified nucleotides
Anthony D. Keefe et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Molecular assembly for high-performance bivalent nucleic acid inhibitor
Youngmi Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Improvement of aptamer affinity by dimerization
Hijiri Hasegawa et al.
SENSORS (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer
Jens Mueller et al.
CHEMBIOCHEM (2007)
SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands
Regina Stoltenburg et al.
BIOMOLECULAR ENGINEERING (2007)
Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition
Katherine Holmes et al.
CELLULAR SIGNALLING (2007)
Molecular mapping and functional characterization of the VEGF164 heparin-binding domain
Dominik Krilleke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro:: Comparison of different tumor cells and primary endothelial cells
Joachim Oswald et al.
CANCER LETTERS (2007)
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
Frank A. Scappaticci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis
Raul Catena et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Transition-metal nanocluster stabilization for catalysis: A critical review of ranking methods and putative stabilizers
Lisa Starkey Ott et al.
COORDINATION CHEMISTRY REVIEWS (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours
Edwina N. Scott et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: An update of recent developments
Neeltje Steeghs et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration
Jost B. Jonas et al.
OPHTHALMIC RESEARCH (2007)
Roles for VEGF in the adult
Arindel S. R. Maharaj et al.
MICROVASCULAR RESEARCH (2007)
Glossary of terms used in Photochemistry 3(rd) Edition (IUPAC Recommendations 2006)
S. E. Braslavsky
PURE AND APPLIED CHEMISTRY (2007)
Metabolism and disposition of vatalanib (PTK787/ZK-222584) in cancer patients
Lorenz M. Jost et al.
DRUG METABOLISM AND DISPOSITION (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Acute hypoxia decreases plasma VEGF concentration in healthy humans
KM Oltmanns et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
EWM Ng et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
G. J. Roboz et al.
LEUKEMIA (2006)
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165
JH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-α and IL-6 by human monocytes
SA Yoo et al.
JOURNAL OF IMMUNOLOGY (2005)
The role of vascular endothelial growth factor \in ocular health and disease
AP Adamis et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease
DIR Holmes et al.
GENOME BIOLOGY (2005)
The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients
H Kakizawa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
The single-step synthesis of a DNA tetrahedron
RP Goodman et al.
CHEMICAL COMMUNICATIONS (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
Vascular endothelial growth factor receptor-2: Its unique signaling and specific ligand, VEGF-E
M Shibuya
CANCER SCIENCE (2003)
Vascular endothelial growth factor-B promotes in vivo angiogenesis
JS Silvestre et al.
CIRCULATION RESEARCH (2003)
Mfold web server for nucleic acid folding and hybridization prediction
M Zuker
NUCLEIC ACIDS RESEARCH (2003)
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584
AL Thomas et al.
SEMINARS IN ONCOLOGY (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
K Koga et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Tumor angiogenesis of non-small cell lung cancer
N Shijubo et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2003)
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
F Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Therapies directed at vascular endothelial growth factor
PW Manley et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak
JOURNAL OF CLINICAL ONCOLOGY (2002)
Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings
ME Stauffer et al.
JOURNAL OF BIOMOLECULAR NMR (2002)
Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: Pharmacologic and long-term safety data
K Margolin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer
MS Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF
Z Gluzman-Poltorak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis
DG Bae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing
K Paavonen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
